Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 27, 2009
Patent Application Number
11818463
Date Filed
June 14, 2007
Patent Citations Received
0
...
Patent Primary Examiner
Patent abstract
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration to the eye. The ophthalmic formulations include a stable liquid formulation and a lyophilizable formulation. Preferably, the protein antagonist has the amino acid sequence shown in SEQ ID NO:4.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.